Silver Springs, MD, United States of America

James J Mond

USPTO Granted Patents = 37 (Patent Applications = 6)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 458(Granted Patents)

Location History:

Potomac, MD (US) (1996 - 1999)
Jerusalem, IL (1999 - 2007)
Silver Springs, MD (US) (2009 - 2014)
Silver Spring, MD (US) (2002 - 2024)

Company Filing History:

10 out of 191

The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

5. 4 out of 4

Adma Biomanufacturing, LLC

patents

6. 1 out of 1

Henry Jackson Foundation

patent

7. 1 out of 99

The University of Sheffield

patents

8. 1 out of 2

Uniformed Services University of the Health Sciences, an Institution of Higher Learning Within the Department of Defense

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

37 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12473351 - Compositions and methods for the treatment of immunodeficiency (2025-11-18),

2. 11897943 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2024-02-13),

3. 11780906 - Compositions and methods for the treatment of immunodeficiency (2023-10-10),

4. 11339206 - Compositions and methods for the treatment of immunodeficiency (2022-05-24),

5. 11084870 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2021-08-10),

6. 10821173 - Multimeric fusion protein vaccine and immunotherapeutic (2020-11-03),

7. 10683343 - Compositions and methods for the treatment of immunodeficiency (2020-06-16),

8. 10259865 - Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection (2019-04-16),

9. 9969793 - Compositions and methods for the treatment of immunodeficiency (2018-05-15),

10. 9962436 - Multimeric fusion protein vaccine and immunotherapeutic (2018-05-08),

11. 9907844 - Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines (2018-03-06),

12. 9815886 - Compositions and methods for the treatment of immunodeficiency (2017-11-14),

13. 9714283 - Compositions and methods for the treatment of immunodeficiency (2017-07-25),

14. 9107906 - Compositions and methods for the treatment of immunodeficiency (2015-08-18),

15. 8741869 - Oligodeoxynucleotide and its use to induce an immune response (2014-06-03),

Title: The Innovative Journey of James J Mond

Introduction: James J Mond, a distinguished inventor hailing from Silver Springs, MD (US), has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: James J Mond's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, James J Mond has a proven track record of developing innovative solutions that have garnered international recognition. His expertise lies in merging technology with healthcare to create impactful tools for professionals.

Collaborations: Throughout his career, James J Mond has collaborated with leading research institutions and universities to further his inventions. His partnerships have led to the successful development and commercialization of several patented technologies.

Conclusion: James J Mond's relentless pursuit of innovation and his passion for creating solutions that address real-world challenges have solidified his position as a trailblazer in the field of technology. His contributions continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.